<seo title="Catalent" metakeywords="catalent business model,industry conclusion catalent,pharmaceutical industry inception,providers drug development" metadescription="Catalent is a global leader in the development and delivery of advanced therapies and technologies for the pharmaceutical, biotechnology, and consumer health industries." />
===Introduction to Catalent===

Catalent is a global leader in the development and delivery of advanced therapies and technologies for the pharmaceutical, biotechnology, and consumer health industries. Founded in 2007, the company has grown to become one of the world’s largest and most comprehensive providers of drug development and delivery solutions. With over 20,000 employees in more than 30 countries, Catalent provides a wide range of services, including drug formulation, clinical trial supply, biologics, and advanced delivery technologies. The company also offers a range of products, including drug delivery systems, packaging, and analytical services.
===History of Catalent===

Catalent was founded in 2007 by a group of experienced pharmaceutical industry professionals. The company was created to provide innovative solutions to the challenges faced by the pharmaceutical industry. Since its inception, Catalent has grown to become a global leader in the development and delivery of advanced therapies and technologies. The company has acquired several companies over the years, including Aptuit, a provider of drug development and manufacturing services, and MedImmune, a biologics manufacturer.
===Business Model of Catalent===

Catalent’s business model is based on providing innovative solutions to the challenges faced by the pharmaceutical industry. The company offers a wide range of services, including drug formulation, clinical trial supply, biologics, and advanced delivery technologies. The company also offers a range of products, including drug delivery systems, packaging, and analytical services. In addition, Catalent provides contract manufacturing services to the pharmaceutical industry.
===Products and Services Offered by Catalent===

Catalent offers a wide range of products and services to the pharmaceutical industry. The company’s products include drug delivery systems, packaging, and analytical services. The company also provides contract manufacturing services, including drug formulation, clinical trial supply, biologics, and advanced delivery technologies. In addition, Catalent offers a range of services, such as regulatory support, [[Supply Chain|supply chain]] management, and quality assurance.
===Financial Performance of Catalent===

Catalent has experienced strong [[Financial Performance|financial performance]] in recent years. In 2020, the company reported revenue of $3.3 billion, an increase of 8.3% from the previous year. The company’s [[Net Income|net income]] also increased by 8.3%, to $541 million. In addition, the company’s [[Cash Flow|cash flow]] from operations increased by 11.3%, to $1.2 billion. The company’s strong financial performance is a testament to its ability to provide innovative solutions to the challenges faced by the pharmaceutical industry.
===Conclusion===

Catalent is a global leader in the development and delivery of advanced therapies and technologies for the pharmaceutical, biotechnology, and consumer health industries. The company offers a wide range of produc